Nicholas M. Pajewski, PhD

About Me

Education: Loyola University of Chicago, 2002; PhD, Medical College of Wisconsin, 2008
Memberships: Institute of Mathematical Statistics; American Association for the Advancement of Science; International Biometric Society, ENAR; International Society for Bayesian Analysis; American Statistical Association; American Society of Human Genetics
Positions: Associate Professor, Biostatistical Sciences
Departments and Affiliations: Biostatistical Sciences; Center for Healthcare Innovations

Limitations of Observational Data in Interpreting SPRINT Results.. Pajewski NM, Supiano MA, Williamson JD. JAMA Intern Med. 2018 Jan; 178(1):154-155.
Intensive Blood-Pressure Treatment and Patient-Reported Outcomes.. Berlowitz DR, Pajewski NM, Kazis LE. N. Engl. J. Med. 2017 11; 377(21):2097.
Systolic Blood Pressure and Mortality: Role of Reverse Causation.. Supiano MA, Pajewski NM, Williamson JD. J Am Geriatr Soc. 2018 Jan; 66(1):205-206.
Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States.. Gower EW, Stein JD, Shekhawat NS, Mikkilineni S, Blachley TS, Pajewski NM. Am. J. Ophthalmol. 2017 Dec; 184:157-166.
Intensive Blood Pressure Control on Gait Speed and Mobility Limitation for Older Adults-Reply.. Odden MC, Williamson JD, Pajewski NM. JAMA Intern Med. 2017 09; 177(9):1396.

View More Publications